This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Universitè Laval. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Ehab Kheadr: Innovator in Bacteriocin Research
Introduction
Ehab Kheadr is a notable inventor based in Sainte-Foy, Canada. He has made significant contributions to the field of microbiology, particularly in the development of bacteriocins. His work focuses on innovative solutions to combat harmful microorganisms.
Latest Patents
Ehab Kheadr holds a patent for an isolated bacteriocin known as Divergicin M35. This invention concerns a composition that includes an effective amount of Divergicin M35, which is utilized to kill or limit the proliferation of various microorganisms. This patent represents a significant advancement in the use of bacteriocins for microbial control.
Career Highlights
Kheadr is affiliated with Université Laval, where he conducts research and contributes to the academic community. His work has garnered attention for its potential applications in health and safety, particularly in food preservation and medical treatments.
Collaborations
Ehab Kheadr has collaborated with esteemed colleagues, including Ismail Fliss and Michel Desbiens. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment for innovation.
Conclusion
Ehab Kheadr's contributions to bacteriocin research exemplify the importance of innovation in addressing microbial challenges. His work not only advances scientific knowledge but also holds promise for practical applications in various industries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile